首页|日本汉方药企业专利布局分析——以株式会社津村为例

日本汉方药企业专利布局分析——以株式会社津村为例

扫码查看
目的 对株式会社津村2000-2022年申请的日本专利和中国专利进行分析,了解其技术研发及专利布局方向,并挖掘其战略处方专利布局,以期对我国中药企业有所启示.方法 在Incopat专利检索数据库上检索2000-2022年株式会社津村申请的专利,对其进行专利标引及专利技术分析.结果 株式会社津村围绕汉方制剂产业链上下游技术开展专利布局,专利布局连续且技术主题丰富,对我国中药企业具有潜在威胁,战略处方专利布局具有策略性.结论 我国企业要制定灵活的专利布局策略,拓宽中药企业专利布局技术覆盖范围,持续研发投入并做好专利防御,策略性搭建重点中药产品专利网.
Patent distribution of Japanese Kampo medicine enterprises-TSUMURA & CO as an example
Objective To analyze the Japanese patents and Chinese patents applied by TSUMURA &CO from 2000 to 2022,to understand its research and patent direction and its strategic prescription patents to enlighten Chinese traditional medicine enterprises.Methods Patents filed by TSUMURA& CO from 2000 to 2022 were searched in Incopat patent search database.The patent indexes were analyzed.Results TSUMURA & CO preparation industry chain was complete,the patent distribution was continuous and rich in technical themes,which posed a potential threat to Chinese traditional medicine enterprises.The prescription patents were strategic.Conclusion Chinese enterprises should form flexible patent strategies,broaden the coverage of patent distribution continue investment in R&D and patent defense and strategically construct key Chinese medicine product patent network.

Japanese Kampo medicineTSUMURA & COpatent distribution

王铁融、刘盼、侯媛媛、曹雅迪、陈宁、衡宇鑫、刘伟

展开 >

北京中医药大学管理学院,北京 100029

北京中医药大学图书馆,北京 100029

北京北中岐黄科技投资管理有限公司,北京 100029

北京中医药大学成果转化中心,北京 100029

展开 >

日本汉方药 株式会社津村 专利布局

国家知识产权局专利专项研究项目

FX202212

2024

中南药学
湖南省药学会

中南药学

CSTPCD
影响因子:0.736
ISSN:1672-2981
年,卷(期):2024.22(5)
  • 8